Mark Cuban's pharmaceuticals startup has partnered with pharmacy benefits manager RxPreferred Benefits, the companies announced, in an effort to offer lower-cost drugs through some employer-sponsored health insurance plans....
Sun Pharmaceutical Industries Limited has announced that one of its wholly-owned subsidiaries has launched Palbociclib, a novel anti-cancer drug, in India for patients who have advanced breast cancer. The company will make the drug available under..
The event is scheduled to be held between February 24 and 26, at the Hyderabad International Convention Center (HICC) in Hyderabad. Ernst and Young will be the knowledge partner of the event...
The government may decide on allowing Serum Institute of India’s (SII) Covovax as a heterologous booster dose, meaning it can be used for people who have taken either Covishield or Covaxin for primary vaccination against Covid-19...
In 2023, it is expected that the shift towards personalised medicine will continue as more and more pharmaceutical companies concentrate on creating medications that are customised for specific individuals.
Sirio Pharma Co., Ltd. (Sirio), a leading global CDMO, has announced the completion of its acquisition of a majority stake in Best Formulations LLC, a California-based contract manufacturer of nutritional supplements and personal care products...
COVAXIN (BBV152; Clinicaltrials.gov, NCT05258669), a whole-virion inactivated COVID-19 investigational vaccine candidate that uses the same vero cell manufacturing platform that has been used in the production of polio vaccines for decades,...
AstraZeneca announced that it will spend around $1.8 billion to acquire the clinical-stage biopharmaceutical company CinCor Pharma Inc., based in the United States, in order to expand its line of heart and kidney medications...
IntoCell, a South Korean biotech that is developing novel antibody drug conjugate (ADC) platform technologies, will provide proprietary drug-linkers developed using their proprietary Ortho-Hydroxy Protected Aryl Sulfate (OHPAS) system and payload...
The Indian pharmaceutical industry was ripe for disruption, & the exigencies built by the covid-19 pandemic provided the e-pharmacy format the highly required push
, CDSCO.jpg)
